English

REPRO MED SYSTEMS INC

EDGAR

KRMD Quarterly report (10-Q) · filed 2026-08-05

Annual consolidated revenue for 2026: about USD 41.13M, using the latest reported figures. The previous period, 2025, was about USD 33.65M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

12 million USD

2026-06-30 · USD

Exact inputs and evidence

Revenue: 12045420 USD Source

Operating margin

5.21%

2026-06-30 · %

Exact inputs and evidence

Operating Income: 626991 USD Source
Revenue: 12045420 USD Source

Operating cash flow

216 thousand USD

2026-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 230776 USD Source
Operating Cash Flow: 14663 USD Source

Cash and cash equivalents: 8.3 million USD 2026-06-30 Source
Exact value

8300000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 46.1 million shares 2026-06-30 Source
Exact value

46148690 shares

Reported share-count change

-0.19% · -86.3 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

46234957 shares · 2025-06-30· Source
46148690 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

45.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 10402163 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 41127366 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 30232038 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 11764624 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 12045420 USD · 2026-04-01 – 2026-06-30 Source

Net income

-1.82 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -777966 USD · 2025-07-01 – 2025-09-30 Source
Net income: -2637926 USD · 2025-01-01 – 2025-12-31 Source
Net income: -2151070 USD · 2025-01-01 – 2025-09-30 Source
Net income: -807078 USD · 2026-01-01 – 2026-03-31 Source
Net income: 252449 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

1.39 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -632351 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -697807 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 462405 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -632351 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 14663 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 230776 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 14663 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

191 thousand USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Capital expenditure: 137817 USD · 2017-03-01 – 2017-12-31 Source
Capital expenditure: 134640 USD · 2017-03-01 – 2017-09-30 Source
Capital expenditure: 4145 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 93185 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 4145 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 188006 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 93185 USD · 2018-01-01 – 2018-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 2 of 11 periods available· newest 2017-02-28
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+22.2%

Prior period

USD 33.65 million

2024-01-01 – 2024-12-31
Current period

USD 41.13 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

41127366 − 33646463 = 7480903 USD

33646463 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
41127366 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · REPRO MED SYSTEMS INC · 2025-12-31 REPRO MED SYSTEMS INC (edgar:704440) Year-over-year change in Revenue: 7480903 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 41127366 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#524625 Filing: 000116169726000052 Input fundies:Revenue: 33646463 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#525102 Filing: 000116169726000052
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 3.43 million

Prior period

−USD 6.07 million

2024-01-01 – 2024-12-31
Current period

−USD 2.64 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-2637926 − -6066633 = 3428707 USD

-6066633 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-2637926 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · REPRO MED SYSTEMS INC · 2025-12-31 REPRO MED SYSTEMS INC (edgar:704440) Year-over-year change in Net income: 3428707 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2637926 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#458252 Filing: 000116169726000052 Input fundies:NetIncome: -6066633 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#458513 Filing: 000116169726000052
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 782,123

Prior period

−USD 319,718

2024-01-01 – 2024-12-31
Current period

USD 462,405

2025-01-01 – 2025-12-31

Exact inputs and evidence

462405 − -319718 = 782123 USD

-319718 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
462405 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · REPRO MED SYSTEMS INC · 2025-12-31 REPRO MED SYSTEMS INC (edgar:704440) Year-over-year change in Operating cash flow: 782123 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 462405 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#469601 Filing: 000116169726000052 Input fundies:OperatingCashFlow: -319718 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#469961 Filing: 000116169726000052
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-01-01 – 2025-12-31

Revenue USD 41.13 million 100% of revenue
Cost of revenue USD 15.52 million 38% of revenue
Operating expenses USD 28.58 million 69% of revenue
Operating income −USD 2.97 million −7.2% of revenue
Tax, interest and other Derived −USD 334,516 −0.8% of revenue
Net income −USD 2.64 million −6.4% of revenue

Cash

Operating cash flow USD 462,405 1.1% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 90%
2017 Operating loss: operating costs were 106% of revenue.
2019 93%
2020 97%
2021 Operating loss: operating costs were 105% of revenue.
2022 Operating loss: operating costs were 130% of revenue.
2023 Operating loss: operating costs were 139% of revenue.
2024 Operating loss: operating costs were 136% of revenue.
2025 Operating loss: operating costs were 119% of revenue.
2026 Operating loss: operating costs were 107% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2015-03-01 – 2016-02-29	12247338	11065954 Derived	1181384	398520 Derived	782864	1793031 Derived	Source 2015-03-01 – 2016-02-29: 12247338 USD Inspect Revenue Open source 2015-03-01 – 2016-02-29: 1181384 USD Inspect Operating Income Open source 2015-03-01 – 2016-02-29: 782864 USD Inspect Net Income Open source 2015-03-01 – 2016-02-29: 1914813 USD Inspect Operating Cash Flow Open source 2015-03-01 – 2016-02-29: 121782 USD Inspect Capital Expenditure Open source
2017 2016-03-01 – 2017-02-28	12293655	13029906 Derived	-736251	-201252 Derived	-534999	-534741 Derived	Source 2016-03-01 – 2017-02-28: 12293655 USD Inspect Revenue Open source 2016-03-01 – 2017-02-28: -736251 USD Inspect Operating Income Open source 2016-03-01 – 2017-02-28: -534999 USD Inspect Net Income Open source 2016-03-01 – 2017-02-28: -331616 USD Inspect Operating Cash Flow Open source 2016-03-01 – 2017-02-28: 203125 USD Inspect Capital Expenditure Open source
2019 2018-01-01 – 2018-12-31	17353737	16189201 Derived	1164536	253966 Derived	910570	Unavailable	Source 2018-01-01 – 2018-12-31: 17353737 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 1164536 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 910570 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 1479662 USD Inspect Operating Cash Flow Open source
2020 2019-01-01 – 2019-12-31	23162621	22576942 Derived	585679	21330 Derived	564349	Unavailable	Source 2019-01-01 – 2019-12-31: 23162621 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 585679 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 564349 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 320620 USD Inspect Operating Cash Flow Open source
2021 2020-01-01 – 2020-12-31	24176448	25431233 Derived	-1254785	-42722 Derived	-1212063	Unavailable	Source 2020-01-01 – 2020-12-31: 24176448 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -1254785 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -1212063 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -743323 USD Inspect Operating Cash Flow Open source
2022 2021-01-01 – 2021-12-31	23490175	30519710 Derived	-7029535	-2466712 Derived	-4562823	Unavailable	Source 2021-01-01 – 2021-12-31: 23490175 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -7029535 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -4562823 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -4319510 USD Inspect Operating Cash Flow Open source
2023 2022-01-01 – 2022-12-31	27896037	38676910 Derived	-10780873	-2119731 Derived	-8661142	Unavailable	Source 2022-01-01 – 2022-12-31: 27896037 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -10780873 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -8661142 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -5404549 USD Inspect Operating Cash Flow Open source
2024 2023-01-01 – 2023-12-31	28517666	38787645 Derived	-10269979	3471083 Derived	-13741062	Unavailable	Source 2023-01-01 – 2023-12-31: 28517666 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -10269979 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -13741062 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -4892553 USD Inspect Operating Cash Flow Open source
2025 2024-01-01 – 2024-12-31	33646463	40092694 Derived	-6446231	-379598 Derived	-6066633	Unavailable	Source 2024-01-01 – 2024-12-31: 33646463 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -6446231 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -6066633 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -319718 USD Inspect Operating Cash Flow Open source
2026 2025-01-01 – 2025-12-31	41127366	44099808 Derived	-2972442	-334516 Derived	-2637926	Unavailable	Source 2025-01-01 – 2025-12-31: 41127366 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -2972442 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -2637926 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 462405 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 41.1M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-02-29	Revenue	12247338	Revenue: 12247338 Open source
20172017-02-28	Revenue	12293655	Revenue: 12293655 Open source
20192018-12-31	Revenue	17353737	Revenue: 17353737 Open source
20202019-12-31	Revenue	23162621	Revenue: 23162621 Open source
20212020-12-31	Revenue	24176448	Revenue: 24176448 Open source
20222021-12-31	Revenue	23490175	Revenue: 23490175 Open source
20232022-12-31	Revenue	27896037	Revenue: 27896037 Open source
20242023-12-31	Revenue	28517666	Revenue: 28517666 Open source
20252024-12-31	Revenue	33646463	Revenue: 33646463 Open source
20262025-12-31	Revenue	41127366	Revenue: 41127366 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

22.2% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-02-29	Year over year	No prior comparable period	Revenue: 12247338 Open source
20172017-02-28	Year over year	0.4%	Revenue: 12293655 Open source Revenue: 12247338 Open source
20192018-12-31	Year over year	No prior comparable period	Revenue: 17353737 Open source
20202019-12-31	Year over year	33.5%	Revenue: 23162621 Open source Revenue: 17353737 Open source
20212020-12-31	Year over year	4.4%	Revenue: 24176448 Open source Revenue: 23162621 Open source
20222021-12-31	Year over year	-2.8%	Revenue: 23490175 Open source Revenue: 24176448 Open source
20232022-12-31	Year over year	18.8%	Revenue: 27896037 Open source Revenue: 23490175 Open source
20242023-12-31	Year over year	2.2%	Revenue: 28517666 Open source Revenue: 27896037 Open source
20252024-12-31	Year over year	18%	Revenue: 33646463 Open source Revenue: 28517666 Open source
20262025-12-31	Year over year	22.2%	Revenue: 41127366 Open source Revenue: 33646463 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7.2% 2026

Net margin -6.4% 2026

Free cash flow margin -4.3% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-02-29	Operating margin	9.6%	Operating Income: 1181384 Open source Revenue: 12247338 Open source
20172017-02-28	Operating margin	-6%	Operating Income: -736251 Open source Revenue: 12293655 Open source
20192018-12-31	Operating margin	6.7%	Operating Income: 1164536 Open source Revenue: 17353737 Open source
20202019-12-31	Operating margin	2.5%	Operating Income: 585679 Open source Revenue: 23162621 Open source
20212020-12-31	Operating margin	-5.2%	Operating Income: -1254785 Open source Revenue: 24176448 Open source
20222021-12-31	Operating margin	-29.9%	Operating Income: -7029535 Open source Revenue: 23490175 Open source
20232022-12-31	Operating margin	-38.6%	Operating Income: -10780873 Open source Revenue: 27896037 Open source
20242023-12-31	Operating margin	-36%	Operating Income: -10269979 Open source Revenue: 28517666 Open source
20252024-12-31	Operating margin	-19.2%	Operating Income: -6446231 Open source Revenue: 33646463 Open source
20262025-12-31	Operating margin	-7.2%	Operating Income: -2972442 Open source Revenue: 41127366 Open source
20162016-02-29	Net margin	6.4%	Net Income: 782864 Open source Revenue: 12247338 Open source
20172017-02-28	Net margin	-4.4%	Net Income: -534999 Open source Revenue: 12293655 Open source
20192018-12-31	Net margin	5.2%	Net Income: 910570 Open source Revenue: 17353737 Open source
20202019-12-31	Net margin	2.4%	Net Income: 564349 Open source Revenue: 23162621 Open source
20212020-12-31	Net margin	-5%	Net Income: -1212063 Open source Revenue: 24176448 Open source
20222021-12-31	Net margin	-19.4%	Net Income: -4562823 Open source Revenue: 23490175 Open source
20232022-12-31	Net margin	-31%	Net Income: -8661142 Open source Revenue: 27896037 Open source
20242023-12-31	Net margin	-48.2%	Net Income: -13741062 Open source Revenue: 28517666 Open source
20252024-12-31	Net margin	-18%	Net Income: -6066633 Open source Revenue: 33646463 Open source
20262025-12-31	Net margin	-6.4%	Net Income: -2637926 Open source Revenue: 41127366 Open source
20162016-02-29	Free cash flow margin	14.6%	Revenue: 12247338 Open source Operating Cash Flow: 1914813 Open source Capital Expenditure: 121782 Open source
20172017-02-28	Free cash flow margin	-4.3%	Revenue: 12293655 Open source Operating Cash Flow: -331616 Open source Capital Expenditure: 203125 Open source
20192018-12-31	Free cash flow margin	Not reported	Revenue: 17353737 Open source Operating Cash Flow: 1479662 Open source
20202019-12-31	Free cash flow margin	Not reported	Revenue: 23162621 Open source Operating Cash Flow: 320620 Open source
20212020-12-31	Free cash flow margin	Not reported	Revenue: 24176448 Open source Operating Cash Flow: -743323 Open source
20222021-12-31	Free cash flow margin	Not reported	Revenue: 23490175 Open source Operating Cash Flow: -4319510 Open source
20232022-12-31	Free cash flow margin	Not reported	Revenue: 27896037 Open source Operating Cash Flow: -5404549 Open source
20242023-12-31	Free cash flow margin	Not reported	Revenue: 28517666 Open source Operating Cash Flow: -4892553 Open source
20252024-12-31	Free cash flow margin	Not reported	Revenue: 33646463 Open source Operating Cash Flow: -319718 Open source
20262025-12-31	Free cash flow margin	Not reported	Revenue: 41127366 Open source Operating Cash Flow: 462405 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 462.4K 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-02-29	Operating cash flow	1914813	Operating Cash Flow: 1914813 Open source
20172017-02-28	Operating cash flow	-331616	Operating Cash Flow: -331616 Open source
20192018-12-31	Operating cash flow	1479662	Operating Cash Flow: 1479662 Open source
20202019-12-31	Operating cash flow	320620	Operating Cash Flow: 320620 Open source
20212020-12-31	Operating cash flow	-743323	Operating Cash Flow: -743323 Open source
20222021-12-31	Operating cash flow	-4319510	Operating Cash Flow: -4319510 Open source
20232022-12-31	Operating cash flow	-5404549	Operating Cash Flow: -5404549 Open source
20242023-12-31	Operating cash flow	-4892553	Operating Cash Flow: -4892553 Open source
20252024-12-31	Operating cash flow	-319718	Operating Cash Flow: -319718 Open source
20262025-12-31	Operating cash flow	462405	Operating Cash Flow: 462405 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -534.7K 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-02-29	Free cash flow	1793031	Operating Cash Flow: 1914813 Open source Capital Expenditure: 121782 Open source
20172017-02-28	Free cash flow	-534741	Operating Cash Flow: -331616 Open source Capital Expenditure: 203125 Open source
20192018-12-31	Free cash flow	Unavailable	Operating Cash Flow: 1479662 Open source
20202019-12-31	Free cash flow	Unavailable	Operating Cash Flow: 320620 Open source
20212020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -743323 Open source
20222021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4319510 Open source
20232022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5404549 Open source
20242023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4892553 Open source
20252024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -319718 Open source
20262025-12-31	Free cash flow	Unavailable	Operating Cash Flow: 462405 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

39.5% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-02-29	Liabilities / assets	15.2%	Total Liabilities: 1276001 Open source Total Assets: 8394300 Open source
20172017-02-28	Liabilities / assets	18.3%	Total Liabilities: 1494202 Open source Total Assets: 8170249 Open source
20192018-12-31	Liabilities / assets	15%	Total Liabilities: 1584232 Open source Total Assets: 10545039 Open source
20202019-12-31	Liabilities / assets	19.1%	Total Liabilities: 2645781 Open source Total Assets: 13881861 Open source
20212020-12-31	Liabilities / assets	9.4%	Total Liabilities: 3761955 Open source Total Assets: 39918934 Open source
20222021-12-31	Liabilities / assets	11.6%	Total Liabilities: 4791976 Open source Total Assets: 41293031 Open source
20232022-12-31	Liabilities / assets	26%	Total Liabilities: 11006480 Open source Total Assets: 42332443 Open source
20242023-12-31	Liabilities / assets	28.5%	Total Liabilities: 8107201 Open source Total Assets: 28460972 Open source
20252024-12-31	Liabilities / assets	38.2%	Total Liabilities: 10404836 Open source Total Assets: 27218515 Open source
20262025-12-31	Liabilities / assets	39.5%	Total Liabilities: 11152257 Open source Total Assets: 28200179 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.44× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-02-29	Current assets / current liabilities	6.43×	Current Assets: 7118647 Open source Current Liabilities: 1107914 Open source
20172017-02-28	Current assets / current liabilities	4.88×	Current Assets: 6779724 Open source Current Liabilities: 1389284 Open source
20192018-12-31	Current assets / current liabilities	5.7×	Current Assets: 9033054 Open source Current Liabilities: 1584232 Open source
20202019-12-31	Current assets / current liabilities	4.94×	Current Assets: 11881323 Open source Current Liabilities: 2406289 Open source
20212020-12-31	Current assets / current liabilities	10.24×	Current Assets: 37525792 Open source Current Liabilities: 3666402 Open source
20222021-12-31	Current assets / current liabilities	7.79×	Current Assets: 37321154 Open source Current Liabilities: 4791976 Open source
20232022-12-31	Current assets / current liabilities	4.28×	Current Assets: 29801636 Open source Current Liabilities: 6958940 Open source
20242023-12-31	Current assets / current liabilities	4.55×	Current Assets: 20255929 Open source Current Liabilities: 4454278 Open source
20252024-12-31	Current assets / current liabilities	2.66×	Current Assets: 19132410 Open source Current Liabilities: 7201820 Open source
20262025-12-31	Current assets / current liabilities	2.44×	Current Assets: 19988790 Open source Current Liabilities: 8194358 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2015-03-01 – 2016-02-29	USD 782,864 Exact value Exact value: 782864 USD 2015-03-01 – 2016-02-29: 782864 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2016-02-29 REPRO MED SYSTEMS INC (edgar:704440) Net Income: 782864 USD Concept: fundies:NetIncome Period: 2015-03-01 to 2016-02-29 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2016-02-29&surface=latest&period_type=duration&start=2015-03-01&unit=USD&dimensions= Input fundies:NetIncome: 782864 USD (2015-03-01 to 2016-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169717000228/repr-20170228.xml#68678 Filing: 000116169717000228 The citation records this snapshot. The page link may show a newer release later.	USD 1.91 million Exact value Exact value: 1914813 USD 2015-03-01 – 2016-02-29: 1914813 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2016-02-29 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: 1914813 USD Concept: fundies:OperatingCashFlow Period: 2015-03-01 to 2016-02-29 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2016-02-29&surface=latest&period_type=duration&start=2015-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1914813 USD (2015-03-01 to 2016-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169717000228/repr-20170228.xml#75204 Filing: 000116169717000228 The citation records this snapshot. The page link may show a newer release later.	USD 121,782 Exact value Exact value: 121782 USD 2015-03-01 – 2016-02-29: 121782 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REPRO MED SYSTEMS INC · 2016-02-29 REPRO MED SYSTEMS INC (edgar:704440) Capital Expenditure: 121782 USD Concept: fundies:CapitalExpenditure Period: 2015-03-01 to 2016-02-29 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ACapitalExpenditure&period=2016-02-29&surface=latest&period_type=duration&start=2015-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 121782 USD (2015-03-01 to 2016-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169717000228/repr-20170228.xml#75611 Filing: 000116169717000228 The citation records this snapshot. The page link may show a newer release later.	USD 1.79 million Calculation and evidence 1914813 − 121782 USD Exact free cash flow: 1793031 USD 2015-03-01 – 2016-02-29: 1914813 USD · Inspect Operating Cash Flow · Source 2015-03-01 – 2016-02-29: 121782 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REPRO MED SYSTEMS INC · 2016-02-29 REPRO MED SYSTEMS INC (edgar:704440) Free cash flow: 1793031 USD Concept: free-cash-flow Period: 2015-03-01 to 2016-02-29 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1914813 USD (2015-03-01 to 2016-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169717000228/repr-20170228.xml#75204 Filing: 000116169717000228 Input fundies:CapitalExpenditure: 121782 USD (2015-03-01 to 2016-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169717000228/repr-20170228.xml#75611 Filing: 000116169717000228 The citation records this snapshot. The page link may show a newer release later.
2017 2016-03-01 – 2017-02-28	−USD 534,999 Exact value Exact value: -534999 USD 2016-03-01 – 2017-02-28: -534999 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2017-02-28 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -534999 USD Concept: fundies:NetIncome Period: 2016-03-01 to 2017-02-28 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2017-02-28&surface=latest&period_type=duration&start=2016-03-01&unit=USD&dimensions= Input fundies:NetIncome: -534999 USD (2016-03-01 to 2017-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169719000049/repr-20180930.xml#118300 Filing: 000116169719000049 The citation records this snapshot. The page link may show a newer release later.	−USD 331,616 Exact value Exact value: -331616 USD 2016-03-01 – 2017-02-28: -331616 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2017-02-28 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: -331616 USD Concept: fundies:OperatingCashFlow Period: 2016-03-01 to 2017-02-28 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2017-02-28&surface=latest&period_type=duration&start=2016-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -331616 USD (2016-03-01 to 2017-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169719000049/repr-20180930.xml#137641 Filing: 000116169719000049 The citation records this snapshot. The page link may show a newer release later.	USD 203,125 Exact value Exact value: 203125 USD 2016-03-01 – 2017-02-28: 203125 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REPRO MED SYSTEMS INC · 2017-02-28 REPRO MED SYSTEMS INC (edgar:704440) Capital Expenditure: 203125 USD Concept: fundies:CapitalExpenditure Period: 2016-03-01 to 2017-02-28 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ACapitalExpenditure&period=2017-02-28&surface=latest&period_type=duration&start=2016-03-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 203125 USD (2016-03-01 to 2017-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169719000049/repr-20180930.xml#138374 Filing: 000116169719000049 The citation records this snapshot. The page link may show a newer release later.	−USD 534,741 Calculation and evidence -331616 − 203125 USD Exact free cash flow: -534741 USD 2016-03-01 – 2017-02-28: -331616 USD · Inspect Operating Cash Flow · Source 2016-03-01 – 2017-02-28: 203125 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REPRO MED SYSTEMS INC · 2017-02-28 REPRO MED SYSTEMS INC (edgar:704440) Free cash flow: -534741 USD Concept: free-cash-flow Period: 2016-03-01 to 2017-02-28 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -331616 USD (2016-03-01 to 2017-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169719000049/repr-20180930.xml#137641 Filing: 000116169719000049 Input fundies:CapitalExpenditure: 203125 USD (2016-03-01 to 2017-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169719000049/repr-20180930.xml#138374 Filing: 000116169719000049 The citation records this snapshot. The page link may show a newer release later.
2019 2018-01-01 – 2018-12-31	USD 910,570 Exact value Exact value: 910570 USD 2018-01-01 – 2018-12-31: 910570 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2018-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: 910570 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 910570 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169720000108/krmd-20191231.xml#65530 Filing: 000116169720000108 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1479662 USD 2018-01-01 – 2018-12-31: 1479662 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2018-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: 1479662 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1479662 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169720000108/krmd-20191231.xml#82786 Filing: 000116169720000108 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-01-01 – 2019-12-31	USD 564,349 Exact value Exact value: 564349 USD 2019-01-01 – 2019-12-31: 564349 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2019-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: 564349 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 564349 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169721000169/krmd-20201231.xml#92175 Filing: 000116169721000169 The citation records this snapshot. The page link may show a newer release later.	USD 320,620 Exact value Exact value: 320620 USD 2019-01-01 – 2019-12-31: 320620 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2019-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: 320620 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 320620 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169721000169/krmd-20201231.xml#94192 Filing: 000116169721000169 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-01-01 – 2020-12-31	−USD 1.21 million Exact value Exact value: -1212063 USD 2020-01-01 – 2020-12-31: -1212063 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2020-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -1212063 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1212063 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169722000133/form_10-k.htm#503161 Filing: 000116169722000133 The citation records this snapshot. The page link may show a newer release later.	−USD 743,323 Exact value Exact value: -743323 USD 2020-01-01 – 2020-12-31: -743323 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2020-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: -743323 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -743323 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169722000133/form_10-k.htm#459278 Filing: 000116169722000133 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2021-01-01 – 2021-12-31	−USD 4.56 million Exact value Exact value: -4562823 USD 2021-01-01 – 2021-12-31: -4562823 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2021-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -4562823 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4562823 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169723000158/form_10-k.htm#502139 Filing: 000116169723000158 The citation records this snapshot. The page link may show a newer release later.	−USD 4.32 million Exact value Exact value: -4319510 USD 2021-01-01 – 2021-12-31: -4319510 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2021-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: -4319510 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4319510 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169723000158/form_10-k.htm#458908 Filing: 000116169723000158 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2022-01-01 – 2022-12-31	−USD 8.66 million Exact value Exact value: -8661142 USD 2022-01-01 – 2022-12-31: -8661142 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2022-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -8661142 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8661142 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169724000139/form_10-k.htm#525541 Filing: 000116169724000139 The citation records this snapshot. The page link may show a newer release later.	−USD 5.4 million Exact value Exact value: -5404549 USD 2022-01-01 – 2022-12-31: -5404549 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2022-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: -5404549 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5404549 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169724000139/form_10-k.htm#472355 Filing: 000116169724000139 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2023-01-01 – 2023-12-31	−USD 13.74 million Exact value Exact value: -13741062 USD 2023-01-01 – 2023-12-31: -13741062 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2023-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -13741062 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13741062 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169725000103/form_10-k.htm#442405 Filing: 000116169725000103 The citation records this snapshot. The page link may show a newer release later.	−USD 4.89 million Exact value Exact value: -4892553 USD 2023-01-01 – 2023-12-31: -4892553 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2023-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: -4892553 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4892553 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169725000103/form_10-k.htm#455269 Filing: 000116169725000103 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2024-01-01 – 2024-12-31	−USD 6.07 million Exact value Exact value: -6066633 USD 2024-01-01 – 2024-12-31: -6066633 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2024-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -6066633 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6066633 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#458513 Filing: 000116169726000052 The citation records this snapshot. The page link may show a newer release later.	−USD 319,718 Exact value Exact value: -319718 USD 2024-01-01 – 2024-12-31: -319718 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2024-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: -319718 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -319718 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#469961 Filing: 000116169726000052 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2026 2025-01-01 – 2025-12-31	−USD 2.64 million Exact value Exact value: -2637926 USD 2025-01-01 – 2025-12-31: -2637926 USD Inspect Net Income Open source Share or cite Citation for Net Income · REPRO MED SYSTEMS INC · 2025-12-31 REPRO MED SYSTEMS INC (edgar:704440) Net Income: -2637926 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2637926 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#458252 Filing: 000116169726000052 The citation records this snapshot. The page link may show a newer release later.	USD 462,405 Exact value Exact value: 462405 USD 2025-01-01 – 2025-12-31: 462405 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REPRO MED SYSTEMS INC · 2025-12-31 REPRO MED SYSTEMS INC (edgar:704440) Operating Cash Flow: 462405 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704440/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 462405 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/form_10-k.htm#469601 Filing: 000116169726000052 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

190 filings · 4,920 latest values · 4,920 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000704440, 704440, KRMD, REPR, edgar:704440

Also known as KORU MEDICAL SYSTEMS, INC, KORU MEDICAL SYSTEMS, INC., KORU Medical Systems, Inc., REPRO MED SYSTEMS INC, REPRO MED SYSTEMS, INC.

REPRO MED SYSTEMS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2026 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation